Asthma With Hypersecretion-associated Gene for Cystic Fibrosis

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

June 30, 2016

Conditions
Asthma
Interventions
GENETIC

Asthma patients

Patients with inclusion criteria, following examinations: a study of lung function measurement of the fraction of nitric oxide in exhaled air, induced sputum, sputum, and extraction of peripheral venous blood for Study of genetic variants in the CFTR gene,skin prick test . The number of eosinophils in peripheral blood by automated cell counting and Total IgE by ELISA were measured. Furthermore, the level of asthma control be assessed by validated symptom questionnaire Asthma Control Test, quality of life is determined by the MiniAQLQ questionnaire.

Trial Locations (1)

08041

Hospital de la Santa Creu i Sant Pau. Carrer Mas Casanovas 90., Barcelona

All Listed Sponsors
lead

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

NCT02558127 - Asthma With Hypersecretion-associated Gene for Cystic Fibrosis | Biotech Hunter | Biotech Hunter